News
Various systemic therapies for psoriasis either reduced, slightly increased or had no effect on risk for major adverse ...
Bimekizumab use for 4 years among patients with plaque psoriasis is associated with sustained efficacy outcomes and no new safety signals.
Patients with uveitis had a higher risk for psoriatic arthritis and psoriasis, whereas those with psoriatic arthritis had a higher risk for uveitis.
Discover why nails separate from the nail bed, what causes onycholysis, and how to treat this common but concerning nail ...
Board-certified dermatologist Dr. Deanne Mraz, recommends this Aveeno bar soap for anyone looking for an ultra-gentle and ...
Global Dermatology Devices Market is expected to grow at a rate of 12% by 2026. Growing awareness on dermatology devices for aesthetic treatments, growing cases of skin diseases & skin cancer, ...
17h
ABP News on MSNStress And Hair Loss In Women — Addressing The Psychosomatic Impact During MonsoonWith the onset of early monsoon in many parts of the country, people are bracing for the many problems the season creates for ...
17h
Lansing State Journal on MSNWhy drug prices vary by hundreds, thousands of dollars at Lansing area hospitalsLansing's two hospitals and systems are charging very different prices for the same medications, a Michigan Health Purchasers Coalition report shows.
Dr. Doshi agrees. “Some shampoos contain ingredients such as minoxidil, ketoconazole, biotin, and saw palmetto that may help ...
The FDA has approved Starjemza (ustekinumab-hmny), a biosimilar to Stelara (ustekinumab), for the treatment of various chronic inflammatory diseases.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results